These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 9472907)

  • 1. Resistance to antimicrobial chemotherapy: a prescription for research and action.
    Levin BR; Antia R; Berliner E; Bloland P; Bonhoeffer S; Cohen M; DeRouin T; Fields PI; Jafari H; Jernigan D; Lipsitch M; McGowan JE; Mead P; Nowak M; Porco T; Sykora P; Simonsen L; Spitznagel J; Tauxe R; Tenover F
    Am J Med Sci; 1998 Feb; 315(2):87-94. PubMed ID: 9472907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The within-host population dynamics of antibacterial chemotherapy: conditions for the evolution of resistance.
    Lipsitch M; Levin BR
    Ciba Found Symp; 1997; 207():112-27; discussion 127-30. PubMed ID: 9189638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Better control of antibiotic resistance.
    Guillemot D; Courvalin P;
    Clin Infect Dis; 2001 Aug; 33(4):542-7. PubMed ID: 11462192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The population genetics of antibiotic resistance.
    Levin BR; Lipsitch M; Perrot V; Schrag S; Antia R; Simonsen L; Walker NM; Stewart FM
    Clin Infect Dis; 1997 Jan; 24 Suppl 1():S9-16. PubMed ID: 8994776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The population dynamics of antimicrobial chemotherapy.
    Lipsitch M; Levin BR
    Antimicrob Agents Chemother; 1997 Feb; 41(2):363-73. PubMed ID: 9021193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reasons for the emergence of antibiotic resistance.
    Tenover FC; McGowan JE
    Am J Med Sci; 1996 Jan; 311(1):9-16. PubMed ID: 8571988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Report from the European Conference on the Role of Research in Combating Antibiotic Resistance, 2003.
    Cornaglia G; Lönnroth A; Struelens M
    Clin Microbiol Infect; 2004 May; 10(5):473-97. PubMed ID: 15113331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rational approach to limiting emergence of antimicrobial drug resistance.
    Mbori-Ngacha DA
    East Afr Med J; 1997 Mar; 74(3):187-9. PubMed ID: 9185420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Why is antibiotic resistance a deadly emerging disease?
    Courvalin P
    Clin Microbiol Infect; 2016 May; 22(5):405-7. PubMed ID: 26806259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging Infections Program as Surveillance for Antimicrobial Drug Resistance.
    Fridkin SK; Cleveland AA; See I; Lynfield R
    Emerg Infect Dis; 2015 Sep; 21(9):1578-81. PubMed ID: 26291638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of bacterial resistance to antimicrobial agents.
    Stratton CW
    J Med Liban; 2000; 48(4):186-98. PubMed ID: 11214188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibiotic resistance in bacteria. A current and future problem.
    Liu HH
    Adv Exp Med Biol; 1999; 455():387-96. PubMed ID: 10599374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monitoring antimicrobial drug resistance in hospital microorganisms. Definition of problems and methods.
    Møller JK
    Dan Med Bull; 1990 Jun; 37(3):263-74. PubMed ID: 2192838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Surveillance and prevalence of antimicrobial resistance in Norway].
    Simonsen GS
    Tidsskr Nor Laegeforen; 2009 Mar; 129(7):623-7. PubMed ID: 19337330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular epidemiology of antibiotic resistance.
    Stefani S; Agodi A
    Int J Antimicrob Agents; 2000 Jan; 13(3):143-53. PubMed ID: 10724018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Society for Healthcare Epidemiology of America and Infectious Diseases Society of America Joint Committee on the Prevention of Antimicrobial Resistance: guidelines for the prevention of antimicrobial resistance in hospitals.
    Shlaes DM; Gerding DN; John JF; Craig WA; Bornstein DL; Duncan RA; Eckman MR; Farrer WE; Greene WH; Lorian V; Levy S; McGowan JE; Paul SM; Ruskin J; Tenover FC; Watanakunakorn C
    Clin Infect Dis; 1997 Sep; 25(3):584-99. PubMed ID: 9314444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New approaches to the control of infections caused by antibiotic-resistant bacteria. An industry perspective.
    Chopra I; Hodgson J; Metcalf B; Poste G
    JAMA; 1996 Feb; 275(5):401-3. PubMed ID: 8569021
    [No Abstract]   [Full Text] [Related]  

  • 18. Antimicrobial resistance in countries with limited resources: unique challenges and limited alternatives.
    Sirinavin S; Dowell SF
    Semin Pediatr Infect Dis; 2004 Apr; 15(2):94-8. PubMed ID: 15185192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies of antibiotic resistance within the patient, hospitals and the community using simple mathematical models.
    Austin DJ; Anderson RM
    Philos Trans R Soc Lond B Biol Sci; 1999 Apr; 354(1384):721-38. PubMed ID: 10365398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The changing epidemiology of resistance.
    Hawkey PM; Jones AM
    J Antimicrob Chemother; 2009 Sep; 64 Suppl 1():i3-10. PubMed ID: 19675017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.